A Phase 2 Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of HRS-7085 Tablets in Patients With Inflammatory Bowel Disease

This study is testing a new pill called HRS-7085 for people with moderate-to-severe ulcerative colitis — a condition that causes long-term inflammation and sores in the large intestine. Researchers want to see if this drug is safe and effective. **You may be eligible if...** - You are between 18 and 75 years old - You have been diagnosed with ulcerative colitis for at least 90 days - Your disease is currently active and causing symptoms (including rectal bleeding) - Previous treatments like steroids, immunosuppressants, or biologic drugs have not worked well enough **You may NOT be eligible if...** - You are under 18 or over 75 years old - You are underweight (BMI below 18) - Your colitis is not currently active - You have Crohn's disease rather than ulcerative colitis - You have a serious infection, liver disease, or other major health problems - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.